Kennedy AD, Solga MD, Schuman TA, Chi AW, Lindorfer MA, Sutherland WM, Foley PL, Taylor RP (2003) An anti-C3b(i) mAb enhances complement activation, C3b(i) deposition, and killing of CD20+ cells by rituximab. Blood 101(3):1071-1079. doi: 10.1182/blood-2002-03-0876 PMID: 12393727
Related Products: Antibody to Complement C3 (3E7) (Cat. #AB-V82)